Home › Therapeutic areas › Cardiovascular › Hereditary Hemorrhagic Telangiectasia
Hereditary Hemorrhagic Telangiectasia (1 companies)
Companies with an active program in Hereditary Hemorrhagic Telangiectasia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| TECX | Tectonic Therapeutic | Cardiovascular Rare | 2 | Phase 2 | $412M | 4 |
No companies match.